BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 6310307)

  • 1. [Trophoblastic beta 1-glycoprotein in the blood in trophoblastic tumors].
    Sokolov AV; Zhordaniia KI; Ledian KM
    Med Radiol (Mosk); 1983 Aug; 28(8):25-31. PubMed ID: 6310307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
    Grinevich IuA; Tatarinov IuS; Iugrinova LG; Olefirenko GA; Dotsenko IuS
    Vopr Onkol; 1981; 27(12):19-23. PubMed ID: 6275607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
    Radikov N
    Akush Ginekol (Sofiia); 1989; 28(2):15-9. PubMed ID: 2548413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pregnancy-specific beta-1 glycoprotein (SP1) as a marker for tumors with or without trophoblastic character].
    Ruibal A; Comet R; Alvarez Moro FJ; Lafuerza A; Domenech-Torné FM; Salvador L
    Rev Esp Oncol; 1984; 31(3):427-34. PubMed ID: 6100801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concanavalin A binding of pregnancy-specific beta-1-glycoprotein in normal pregnancy and trophoblastic disease.
    Koistinen R; Heikinheimo M; Rutanen EM; Stenman UH; Lee JN; Seppälä M
    Oncodev Biol Med; 1981; 2(3):179-82. PubMed ID: 6272237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
    Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
    Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
    Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
    Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels.
    Cole LA; Kohorn EI; Kim GS
    J Reprod Med; 1994 Mar; 39(3):193-200. PubMed ID: 8035374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
    Kohorn EI
    Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pituitary gonadotropic function in uterine trophoblastic tumor].
    Lomonosova MV; Savinskaia AP; Molodyk AA; Gorshkova IA
    Med Radiol (Mosk); 1983 Aug; 28(8):40-4. PubMed ID: 6310308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory investigation of a virilized woman with placental-site trophoblastic tumor.
    Nagelberg SB; Rosen SW
    Obstet Gynecol; 1985 Apr; 65(4):527-34. PubMed ID: 2984618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of the trophoblastic beta 1-globulin and chorionic gonadotropin indices and the clinical course of the disease in uterine chorionepithelioma].
    Zhordina KI; Sokolov AV; Kadagidze ZG; Molodyk AA
    Akush Ginekol (Mosk); 1981 Jul; (7):55-6. PubMed ID: 6975579
    [No Abstract]   [Full Text] [Related]  

  • 14. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
    Rutanen EM; Seppälä M
    J Clin Endocrinol Metab; 1980 Jan; 50(1):57-61. PubMed ID: 6243133
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating placental proteins (hCG, SP1 and PP5) in trophoblastic disease.
    Lee JN; Salem HT; Chard T; Huang SC; Ouyang PC
    Br J Obstet Gynaecol; 1982 Jan; 89(1):69-72. PubMed ID: 6277363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of RIA kit for measuring pregnancy-specific beta 1 glycoprotein (SP1) and its clinical significance as a tumor marker (author's transl)].
    Tsujino D; Chida R; Sasaki Y; Someya K; Shibata K
    Radioisotopes; 1981 Sep; 30(9):502-4. PubMed ID: 6276932
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis and treatment of trophoblastic uterine tumors].
    Kozachenko VP; Toloknov BO; Savinova VF; Grigorova TM
    Vopr Onkol; 1982; 28(5):97-103. PubMed ID: 6283736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pregnancy specific beta-1-glycoprotein].
    Seppälä M; Rutanen EM
    Duodecim; 1979; 95(22):1490-8. PubMed ID: 230953
    [No Abstract]   [Full Text] [Related]  

  • 19. [The clinical significance of the immunoenzyme determination of trophoblastic beta 1-glycoprotein].
    Bogdanovich RN; Berestovaia TA
    Lab Delo; 1990; (9):43-5. PubMed ID: 1702860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hCG assay in the treatment of trophoblastic disease.
    Pattillo RA; Hussa RO
    J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.